Sodium-Glucose Cotransporter-2 Inhibitors: Heart Failure and Renal Protection Indications

被引：2
|
作者：
El Hussein, Mohamed Toufic [1 ,2 ,3 ]
Bell, Nicole [4 ]
机构：
[1] Mt Royal Univ Calgary, Fac Hlth Community & Educ, Sch Nursing & Midwifery, Calgary, AB, Canada
[2] Univ Calgary Calgary, Fac Nursing, Calgary, AB, Canada
[3] Rockyview Gen Hosp Calgary, Coronary Care Unit, Med Cardiol, Calgary, AB, Canada
[4] Mt Royal Univ, Calgary, AB, Canada
来源：
JNP- THE JOURNAL FOR NURSE PRACTITIONERS | 2022年 / 18卷 / 02期
关键词：
heart failure; renal failure; sodium-glucose cotransporter-2 inhibitors; type; 2; diabetes; CARDIOVASCULAR EVENTS; EMPAGLIFLOZIN; RATIONALE; DESIGN; RISK;
D O I：
10.1016/j.nurpra.2021.09.002
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) are a class of oral antihyperglycemic drugs recently added to clinical practice guidelines to manage type 2 diabetes mellitus (T2DM). Recent clinical trials have established significant benefits in using SGLT-2is to treat both heart failure and renal disease. This article aims to explain the clinical benefits of inhibiting sodium-glucose cotransporter-2 proteins in patients with T2DM, renal disease, and heart failure. These authors also seek to guide nurse practitioners in prescribing SGLT-2is. Evidence-based guidance for nurse practitioners to treat T2DM, heart failure, and renal disease is likely to improve patients' clinical outcomes and decrease associated morbidities. (c) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码：179 / 184
页数：6
相关论文
共 50 条
  • [1] Mechanisms of cardio-renal protection of sodium-glucose cotransporter-2 inhibitors
    Chiriaco, Martina
    Trico, Domenico
    Solini, Anna
    CURRENT OPINION IN PHARMACOLOGY, 2022, 66
  • [2] Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature
    Mckenzie, Taylor
    Hale, Genevieve M.
    Miner, Amelia
    Colon, Jean Colon
    Evins, Garrett
    Wade, Jasmine
    HEART FAILURE REVIEWS, 2024, 29 (02) : 549 - 558
  • [3] Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature
    Taylor McKenzie
    Genevieve M. Hale
    Amelia Miner
    Jean Colón Colón
    Garrett Evins
    Jasmine Wade
    Heart Failure Reviews, 2024, 29 : 549 - 558
  • [4] Timing and Adherence Matter for Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure
    Yilmaz, Mehmet Birhan
    Celik, Ahmet
    Sahin, Anil
    Colluoglu, Tugce
    Ural, Dilek
    Kanik, Arzu
    Ata, Naim
    Ulgu, Mustafa Mahir
    Birinci, Suayip
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (07):
  • [5] Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure: The New Kid on the Block
    McDermott, Jaime
    Tennyson, Carolina
    Bell-McClure, Elizabeth
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2021, 17 (06): : 652 - 656
  • [6] Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update
    Profili, Nicia I.
    Castelli, Roberto
    Gidaro, Antonio
    Manetti, Roberto
    Maioli, Margherita
    Delitala, Alessandro P.
    PHARMACEUTICALS, 2024, 17 (11)
  • [7] Potential global impact of sodium-glucose cotransporter-2 inhibitors in heart failure
    Talha, Khawaja M.
    Butler, Javed
    Greene, Stephen J.
    Aggarwal, Rahul
    Anker, Stefan D.
    Claggett, Brian L.
    Docherty, Kieran F.
    Solomon, Scott D.
    McMurray, John J. V.
    Januzzi, James L.
    Vaduganathan, Muthiah
    Fonarow, Gregg C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (07) : 999 - 1009
  • [8] Sodium-glucose cotransporter-2 inhibitors for heart failure with reduced ejection fraction
    Falk, Jamie
    Potter, Jennifer
    Turgeon, Ricky D.
    CANADIAN FAMILY PHYSICIAN, 2021, 67 (09) : 678 - 678
  • [9] Renal Protection and Safety of Sodium-glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease
    Zhou, Tianbiao
    Yao, Kaijin
    Xie, Yina
    Lin, Yongda
    Wang, Jiali
    Chen, Xiutian
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (21) : 1659 - 1670
  • [10] Diving into the unknown: sodium-glucose cotransporter-2 inhibitors in heart failure without diabetes
    Seferovic, Petar M.
    Seferovic, Jelena P.
    Polovina, Marija M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (07) : 874 - 876
12345